Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

NCT01989910 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

107

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Raltegravir
DRUG: Efavirenz

Sponsor

Taipei Veterans General Hospital, Taiwan